Pharma & Healthcare
Global Albumin (as Excipient) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 438596
- Pages: 96
- Figures: 95
- Views: 2
The global Albumin (as Excipient) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
By Type: (Dominant Segment vs High-Margin Innovation)
Human Serum Albumin
Recombinant Albumin
By Application: (Core Demand Driver vs Emerging Opportunity)
Cell Culture Media
Medical Supplements
Therapeutics
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL in Europe)
- Emerging Product Trends: Human Serum Albumin adoption vs. Recombinant Albumin premiumization
- Demand-Side Dynamics: Cell Culture Media growth in China vs. Medical Supplements potential in United States
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
United States
Europe
China
Japan
Australia
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Albumin (as Excipient) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Recombinant Albumin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medical Supplements in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Human Serum Albumin dominance in Europe vs. Recombinant Albumin demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
By Type: (Dominant Segment vs High-Margin Innovation)
Human Serum Albumin
Recombinant Albumin
By Application: (Core Demand Driver vs Emerging Opportunity)
Cell Culture Media
Medical Supplements
Therapeutics
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL in Europe)
- Emerging Product Trends: Human Serum Albumin adoption vs. Recombinant Albumin premiumization
- Demand-Side Dynamics: Cell Culture Media growth in China vs. Medical Supplements potential in United States
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
United States
Europe
China
Japan
Australia
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Albumin (as Excipient) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Recombinant Albumin in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medical Supplements in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Human Serum Albumin dominance in Europe vs. Recombinant Albumin demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Albumin (as Excipient) Product Scope
1.2 Albumin (as Excipient) by Type
1.2.1 Global Albumin (as Excipient) Sales by Type (2020 & 2024 & 2031)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) by Application
1.3.1 Global Albumin (as Excipient) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Global Albumin (as Excipient) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Albumin (as Excipient) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Albumin (as Excipient) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Albumin (as Excipient) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Albumin (as Excipient) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Albumin (as Excipient) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Albumin (as Excipient) Sales Market Share by Region (2020-2025)
2.2.2 Global Albumin (as Excipient) Revenue Market Share by Region (2020-2025)
2.3 Global Albumin (as Excipient) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Albumin (as Excipient) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Albumin (as Excipient) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 United States Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.2 Europe Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.3 China Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.4 Japan Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.5 Australia Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.6 India Albumin (as Excipient) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Albumin (as Excipient) Historic Market Review by Type (2020-2025)
3.1.1 Global Albumin (as Excipient) Sales by Type (2020-2025)
3.1.2 Global Albumin (as Excipient) Revenue by Type (2020-2025)
3.1.3 Global Albumin (as Excipient) Price by Type (2020-2025)
3.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Albumin (as Excipient) Sales Forecast by Type (2026-2031)
3.2.2 Global Albumin (as Excipient) Revenue Forecast by Type (2026-2031)
3.2.3 Global Albumin (as Excipient) Price Forecast by Type (2026-2031)
3.3 Different Types Albumin (as Excipient) Representative Players
4 Global Market Size by Application
4.1 Global Albumin (as Excipient) Historic Market Review by Application (2020-2025)
4.1.1 Global Albumin (as Excipient) Sales by Application (2020-2025)
4.1.2 Global Albumin (as Excipient) Revenue by Application (2020-2025)
4.1.3 Global Albumin (as Excipient) Price by Application (2020-2025)
4.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Albumin (as Excipient) Sales Forecast by Application (2026-2031)
4.2.2 Global Albumin (as Excipient) Revenue Forecast by Application (2026-2031)
4.2.3 Global Albumin (as Excipient) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Albumin (as Excipient) Application
5 Competition Landscape by Players
5.1 Global Albumin (as Excipient) Sales by Players (2020-2025)
5.2 Global Top Albumin (as Excipient) Players by Revenue (2020-2025)
5.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
5.4 Global Albumin (as Excipient) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
5.7 Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 United States Market: Players, Segments, Downstream and Major Customers
6.1.1 United States Albumin (as Excipient) Sales by Company
6.1.1.1 United States Albumin (as Excipient) Sales by Company (2020-2025)
6.1.1.2 United States Albumin (as Excipient) Revenue by Company (2020-2025)
6.1.2 United States Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.1.3 United States Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.1.4 United States Albumin (as Excipient) Major Customer
6.1.5 United States Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Albumin (as Excipient) Sales by Company
6.2.1.1 Europe Albumin (as Excipient) Sales by Company (2020-2025)
6.2.1.2 Europe Albumin (as Excipient) Revenue by Company (2020-2025)
6.2.2 Europe Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Albumin (as Excipient) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Albumin (as Excipient) Sales by Company
6.3.1.1 China Albumin (as Excipient) Sales by Company (2020-2025)
6.3.1.2 China Albumin (as Excipient) Revenue by Company (2020-2025)
6.3.2 China Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.3.3 China Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.3.4 China Albumin (as Excipient) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Albumin (as Excipient) Sales by Company
6.4.1.1 Japan Albumin (as Excipient) Sales by Company (2020-2025)
6.4.1.2 Japan Albumin (as Excipient) Revenue by Company (2020-2025)
6.4.2 Japan Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Albumin (as Excipient) Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Australia Market: Players, Segments, Downstream and Major Customers
6.5.1 Australia Albumin (as Excipient) Sales by Company
6.5.1.1 Australia Albumin (as Excipient) Sales by Company (2020-2025)
6.5.1.2 Australia Albumin (as Excipient) Revenue by Company (2020-2025)
6.5.2 Australia Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.5.3 Australia Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.5.4 Australia Albumin (as Excipient) Major Customer
6.5.5 Australia Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Albumin (as Excipient) Sales by Company
6.6.1.1 India Albumin (as Excipient) Sales by Company (2020-2025)
6.6.1.2 India Albumin (as Excipient) Revenue by Company (2020-2025)
6.6.2 India Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.6.3 India Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.6.4 India Albumin (as Excipient) Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CSL
7.1.1 CSL Company Information
7.1.2 CSL Business Overview
7.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CSL Albumin (as Excipient) Products Offered
7.1.5 CSL Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Albumin (as Excipient) Products Offered
7.2.5 Grifols Recent Development
7.3 Takeda
7.3.1 Takeda Company Information
7.3.2 Takeda Business Overview
7.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Takeda Albumin (as Excipient) Products Offered
7.3.5 Takeda Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Octapharma Albumin (as Excipient) Products Offered
7.4.5 Octapharma Recent Development
7.5 Hualan Bio
7.5.1 Hualan Bio Company Information
7.5.2 Hualan Bio Business Overview
7.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Hualan Bio Albumin (as Excipient) Products Offered
7.5.5 Hualan Bio Recent Development
7.6 CBPO
7.6.1 CBPO Company Information
7.6.2 CBPO Business Overview
7.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 CBPO Albumin (as Excipient) Products Offered
7.6.5 CBPO Recent Development
7.7 Shanghai RAAS
7.7.1 Shanghai RAAS Company Information
7.7.2 Shanghai RAAS Business Overview
7.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Shanghai RAAS Albumin (as Excipient) Products Offered
7.7.5 Shanghai RAAS Recent Development
7.8 Kedrion
7.8.1 Kedrion Company Information
7.8.2 Kedrion Business Overview
7.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Kedrion Albumin (as Excipient) Products Offered
7.8.5 Kedrion Recent Development
7.9 LFB Group
7.9.1 LFB Group Company Information
7.9.2 LFB Group Business Overview
7.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 LFB Group Albumin (as Excipient) Products Offered
7.9.5 LFB Group Recent Development
7.10 Albumedix
7.10.1 Albumedix Company Information
7.10.2 Albumedix Business Overview
7.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Albumedix Albumin (as Excipient) Products Offered
7.10.5 Albumedix Recent Development
7.11 Biotest
7.11.1 Biotest Company Information
7.11.2 Biotest Business Overview
7.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Biotest Albumin (as Excipient) Products Offered
7.11.5 Biotest Recent Development
7.12 Merck
7.12.1 Merck Company Information
7.12.2 Merck Business Overview
7.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Merck Albumin (as Excipient) Products Offered
7.12.5 Merck Recent Development
7.13 Ventria (InVitria)
7.13.1 Ventria (InVitria) Company Information
7.13.2 Ventria (InVitria) Business Overview
7.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Ventria (InVitria) Albumin (as Excipient) Products Offered
7.13.5 Ventria (InVitria) Recent Development
7.14 HiMedia
7.14.1 HiMedia Company Information
7.14.2 HiMedia Business Overview
7.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.14.4 HiMedia Albumin (as Excipient) Products Offered
7.14.5 HiMedia Recent Development
8 Albumin (as Excipient) Manufacturing Cost Analysis
8.1 Albumin (as Excipient) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Albumin (as Excipient)
8.4 Albumin (as Excipient) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Albumin (as Excipient) Distributors List
9.3 Albumin (as Excipient) Customers
10 Albumin (as Excipient) Market Dynamics
10.1 Albumin (as Excipient) Industry Trends
10.2 Albumin (as Excipient) Market Drivers
10.3 Albumin (as Excipient) Market Challenges
10.4 Albumin (as Excipient) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Albumin (as Excipient) Product Scope
1.2 Albumin (as Excipient) by Type
1.2.1 Global Albumin (as Excipient) Sales by Type (2020 & 2024 & 2031)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) by Application
1.3.1 Global Albumin (as Excipient) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Global Albumin (as Excipient) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Albumin (as Excipient) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Albumin (as Excipient) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Albumin (as Excipient) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Albumin (as Excipient) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Albumin (as Excipient) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Albumin (as Excipient) Sales Market Share by Region (2020-2025)
2.2.2 Global Albumin (as Excipient) Revenue Market Share by Region (2020-2025)
2.3 Global Albumin (as Excipient) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Albumin (as Excipient) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Albumin (as Excipient) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 United States Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.2 Europe Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.3 China Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.4 Japan Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.5 Australia Albumin (as Excipient) Market Size and Prospective (2020-2031)
2.4.6 India Albumin (as Excipient) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Albumin (as Excipient) Historic Market Review by Type (2020-2025)
3.1.1 Global Albumin (as Excipient) Sales by Type (2020-2025)
3.1.2 Global Albumin (as Excipient) Revenue by Type (2020-2025)
3.1.3 Global Albumin (as Excipient) Price by Type (2020-2025)
3.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Albumin (as Excipient) Sales Forecast by Type (2026-2031)
3.2.2 Global Albumin (as Excipient) Revenue Forecast by Type (2026-2031)
3.2.3 Global Albumin (as Excipient) Price Forecast by Type (2026-2031)
3.3 Different Types Albumin (as Excipient) Representative Players
4 Global Market Size by Application
4.1 Global Albumin (as Excipient) Historic Market Review by Application (2020-2025)
4.1.1 Global Albumin (as Excipient) Sales by Application (2020-2025)
4.1.2 Global Albumin (as Excipient) Revenue by Application (2020-2025)
4.1.3 Global Albumin (as Excipient) Price by Application (2020-2025)
4.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Albumin (as Excipient) Sales Forecast by Application (2026-2031)
4.2.2 Global Albumin (as Excipient) Revenue Forecast by Application (2026-2031)
4.2.3 Global Albumin (as Excipient) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Albumin (as Excipient) Application
5 Competition Landscape by Players
5.1 Global Albumin (as Excipient) Sales by Players (2020-2025)
5.2 Global Top Albumin (as Excipient) Players by Revenue (2020-2025)
5.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
5.4 Global Albumin (as Excipient) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
5.7 Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 United States Market: Players, Segments, Downstream and Major Customers
6.1.1 United States Albumin (as Excipient) Sales by Company
6.1.1.1 United States Albumin (as Excipient) Sales by Company (2020-2025)
6.1.1.2 United States Albumin (as Excipient) Revenue by Company (2020-2025)
6.1.2 United States Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.1.3 United States Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.1.4 United States Albumin (as Excipient) Major Customer
6.1.5 United States Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Albumin (as Excipient) Sales by Company
6.2.1.1 Europe Albumin (as Excipient) Sales by Company (2020-2025)
6.2.1.2 Europe Albumin (as Excipient) Revenue by Company (2020-2025)
6.2.2 Europe Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Albumin (as Excipient) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Albumin (as Excipient) Sales by Company
6.3.1.1 China Albumin (as Excipient) Sales by Company (2020-2025)
6.3.1.2 China Albumin (as Excipient) Revenue by Company (2020-2025)
6.3.2 China Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.3.3 China Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.3.4 China Albumin (as Excipient) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Albumin (as Excipient) Sales by Company
6.4.1.1 Japan Albumin (as Excipient) Sales by Company (2020-2025)
6.4.1.2 Japan Albumin (as Excipient) Revenue by Company (2020-2025)
6.4.2 Japan Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Albumin (as Excipient) Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Australia Market: Players, Segments, Downstream and Major Customers
6.5.1 Australia Albumin (as Excipient) Sales by Company
6.5.1.1 Australia Albumin (as Excipient) Sales by Company (2020-2025)
6.5.1.2 Australia Albumin (as Excipient) Revenue by Company (2020-2025)
6.5.2 Australia Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.5.3 Australia Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.5.4 Australia Albumin (as Excipient) Major Customer
6.5.5 Australia Market Trend and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Albumin (as Excipient) Sales by Company
6.6.1.1 India Albumin (as Excipient) Sales by Company (2020-2025)
6.6.1.2 India Albumin (as Excipient) Revenue by Company (2020-2025)
6.6.2 India Albumin (as Excipient) Sales Breakdown by Type (2020-2025)
6.6.3 India Albumin (as Excipient) Sales Breakdown by Application (2020-2025)
6.6.4 India Albumin (as Excipient) Major Customer
6.6.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 CSL
7.1.1 CSL Company Information
7.1.2 CSL Business Overview
7.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 CSL Albumin (as Excipient) Products Offered
7.1.5 CSL Recent Development
7.2 Grifols
7.2.1 Grifols Company Information
7.2.2 Grifols Business Overview
7.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Grifols Albumin (as Excipient) Products Offered
7.2.5 Grifols Recent Development
7.3 Takeda
7.3.1 Takeda Company Information
7.3.2 Takeda Business Overview
7.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Takeda Albumin (as Excipient) Products Offered
7.3.5 Takeda Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Octapharma Albumin (as Excipient) Products Offered
7.4.5 Octapharma Recent Development
7.5 Hualan Bio
7.5.1 Hualan Bio Company Information
7.5.2 Hualan Bio Business Overview
7.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Hualan Bio Albumin (as Excipient) Products Offered
7.5.5 Hualan Bio Recent Development
7.6 CBPO
7.6.1 CBPO Company Information
7.6.2 CBPO Business Overview
7.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 CBPO Albumin (as Excipient) Products Offered
7.6.5 CBPO Recent Development
7.7 Shanghai RAAS
7.7.1 Shanghai RAAS Company Information
7.7.2 Shanghai RAAS Business Overview
7.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Shanghai RAAS Albumin (as Excipient) Products Offered
7.7.5 Shanghai RAAS Recent Development
7.8 Kedrion
7.8.1 Kedrion Company Information
7.8.2 Kedrion Business Overview
7.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Kedrion Albumin (as Excipient) Products Offered
7.8.5 Kedrion Recent Development
7.9 LFB Group
7.9.1 LFB Group Company Information
7.9.2 LFB Group Business Overview
7.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 LFB Group Albumin (as Excipient) Products Offered
7.9.5 LFB Group Recent Development
7.10 Albumedix
7.10.1 Albumedix Company Information
7.10.2 Albumedix Business Overview
7.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Albumedix Albumin (as Excipient) Products Offered
7.10.5 Albumedix Recent Development
7.11 Biotest
7.11.1 Biotest Company Information
7.11.2 Biotest Business Overview
7.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Biotest Albumin (as Excipient) Products Offered
7.11.5 Biotest Recent Development
7.12 Merck
7.12.1 Merck Company Information
7.12.2 Merck Business Overview
7.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Merck Albumin (as Excipient) Products Offered
7.12.5 Merck Recent Development
7.13 Ventria (InVitria)
7.13.1 Ventria (InVitria) Company Information
7.13.2 Ventria (InVitria) Business Overview
7.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Ventria (InVitria) Albumin (as Excipient) Products Offered
7.13.5 Ventria (InVitria) Recent Development
7.14 HiMedia
7.14.1 HiMedia Company Information
7.14.2 HiMedia Business Overview
7.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
7.14.4 HiMedia Albumin (as Excipient) Products Offered
7.14.5 HiMedia Recent Development
8 Albumin (as Excipient) Manufacturing Cost Analysis
8.1 Albumin (as Excipient) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Albumin (as Excipient)
8.4 Albumin (as Excipient) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Albumin (as Excipient) Distributors List
9.3 Albumin (as Excipient) Customers
10 Albumin (as Excipient) Market Dynamics
10.1 Albumin (as Excipient) Industry Trends
10.2 Albumin (as Excipient) Market Drivers
10.3 Albumin (as Excipient) Market Challenges
10.4 Albumin (as Excipient) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Albumin (as Excipient) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Albumin (as Excipient) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Albumin (as Excipient) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Albumin (as Excipient) Sales (MT) by Region (2020-2025)
Table 5. Global Albumin (as Excipient) Sales Market Share by Region (2020-2025)
Table 6. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Albumin (as Excipient) Revenue Share by Region (2020-2025)
Table 8. Global Albumin (as Excipient) Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Albumin (as Excipient) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Albumin (as Excipient) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Albumin (as Excipient) Sales by Type (MT) & (2020-2025)
Table 13. Global Albumin (as Excipient) Sales Share by Type (2020-2025)
Table 14. Global Albumin (as Excipient) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Albumin (as Excipient) Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Albumin (as Excipient) Sales by Type (MT) & (2026-2031)
Table 17. Global Albumin (as Excipient) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Albumin (as Excipient) Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Albumin (as Excipient) Sales by Application (MT) & (2020-2025)
Table 21. Global Albumin (as Excipient) Sales Share by Application (2020-2025)
Table 22. Global Albumin (as Excipient) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Albumin (as Excipient) Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Albumin (as Excipient) Sales by Application (MT) & (2026-2031)
Table 25. Global Albumin (as Excipient) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Albumin (as Excipient) Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Albumin (as Excipient) Application
Table 28. Global Albumin (as Excipient) Sales by Company (MT) & (2020-2025)
Table 29. Global Albumin (as Excipient) Sales Share by Company (2020-2025)
Table 30. Global Albumin (as Excipient) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Albumin (as Excipient) Revenue Share by Company (2020-2025)
Table 32. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
Table 33. Global Market Albumin (as Excipient) Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
Table 36. Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. United States Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 39. United States Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 40. United States Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 41. United States Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 42. United States Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 43. United States Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 44. United States Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 45. United States Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 46. Europe Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 47. Europe Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 48. Europe Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 50. Europe Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 51. Europe Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 52. Europe Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 53. Europe Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 54. China Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 55. China Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 56. China Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 58. China Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 59. China Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 60. China Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 61. China Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 62. Japan Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 63. Japan Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 64. Japan Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 66. Japan Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 67. Japan Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 68. Japan Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 69. Japan Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 70. Australia Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 71. Australia Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 72. Australia Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 73. Australia Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 74. Australia Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 75. Australia Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 76. Australia Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 77. Australia Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 78. India Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 79. India Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 80. India Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 82. India Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 83. India Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 84. India Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 85. India Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 86. CSL Company Information
Table 87. CSL Description and Business Overview
Table 88. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 89. CSL Albumin (as Excipient) Product
Table 90. CSL Recent Development
Table 91. Grifols Company Information
Table 92. Grifols Description and Business Overview
Table 93. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 94. Grifols Albumin (as Excipient) Product
Table 95. Grifols Recent Development
Table 96. Takeda Company Information
Table 97. Takeda Description and Business Overview
Table 98. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 99. Takeda Albumin (as Excipient) Product
Table 100. Takeda Recent Development
Table 101. Octapharma Company Information
Table 102. Octapharma Description and Business Overview
Table 103. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. Octapharma Albumin (as Excipient) Product
Table 105. Octapharma Recent Development
Table 106. Hualan Bio Company Information
Table 107. Hualan Bio Description and Business Overview
Table 108. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 109. Hualan Bio Albumin (as Excipient) Product
Table 110. Hualan Bio Recent Development
Table 111. CBPO Company Information
Table 112. CBPO Description and Business Overview
Table 113. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 114. CBPO Albumin (as Excipient) Product
Table 115. CBPO Recent Development
Table 116. Shanghai RAAS Company Information
Table 117. Shanghai RAAS Description and Business Overview
Table 118. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 119. Shanghai RAAS Albumin (as Excipient) Product
Table 120. Shanghai RAAS Recent Development
Table 121. Kedrion Company Information
Table 122. Kedrion Description and Business Overview
Table 123. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 124. Kedrion Albumin (as Excipient) Product
Table 125. Kedrion Recent Development
Table 126. LFB Group Company Information
Table 127. LFB Group Description and Business Overview
Table 128. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 129. LFB Group Albumin (as Excipient) Product
Table 130. LFB Group Recent Development
Table 131. Albumedix Company Information
Table 132. Albumedix Description and Business Overview
Table 133. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 134. Albumedix Albumin (as Excipient) Product
Table 135. Albumedix Recent Development
Table 136. Biotest Company Information
Table 137. Biotest Description and Business Overview
Table 138. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 139. Biotest Albumin (as Excipient) Product
Table 140. Biotest Recent Development
Table 141. Merck Company Information
Table 142. Merck Description and Business Overview
Table 143. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 144. Merck Albumin (as Excipient) Product
Table 145. Merck Recent Development
Table 146. Ventria (InVitria) Company Information
Table 147. Ventria (InVitria) Description and Business Overview
Table 148. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 149. Ventria (InVitria) Albumin (as Excipient) Product
Table 150. Ventria (InVitria) Recent Development
Table 151. HiMedia Company Information
Table 152. HiMedia Description and Business Overview
Table 153. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 154. HiMedia Albumin (as Excipient) Product
Table 155. HiMedia Recent Development
Table 156. Production Base and Market Concentration Rate of Raw Material
Table 157. Key Suppliers of Raw Materials
Table 158. Albumin (as Excipient) Distributors List
Table 159. Albumin (as Excipient) Customers List
Table 160. Albumin (as Excipient) Market Trends
Table 161. Albumin (as Excipient) Market Drivers
Table 162. Albumin (as Excipient) Market Challenges
Table 163. Albumin (as Excipient) Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Albumin (as Excipient) Product Picture
Figure 2. Global Albumin (as Excipient) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Albumin (as Excipient) Sales Market Share by Type in 2024 & 2031
Figure 4. Human Serum Albumin Product Picture
Figure 5. Recombinant Albumin Product Picture
Figure 6. Global Albumin (as Excipient) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Albumin (as Excipient) Sales Market Share by Application in 2024 & 2031
Figure 8. Cell Culture Media Examples
Figure 9. Medical Supplements Examples
Figure 10. Therapeutics Examples
Figure 11. Global Albumin (as Excipient) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Albumin (as Excipient) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 14. Global Albumin (as Excipient) Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 15. Albumin (as Excipient) Report Years Considered
Figure 16. Global Market Albumin (as Excipient) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Albumin (as Excipient) Revenue Market Share by Region: 2020 VS 2024
Figure 18. United States Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. United States Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 20. Europe Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 22. China Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 24. Japan Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 26. Australia Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Australia Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 28. India Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 30. Global Albumin (as Excipient) Revenue Share by Type (2020-2025)
Figure 31. Global Albumin (as Excipient) Sales Share by Type (2026-2031)
Figure 32. Global Albumin (as Excipient) Revenue Share by Type (2026-2031)
Figure 33. Global Albumin (as Excipient) Revenue Share by Application (2020-2025)
Figure 34. Global Albumin (as Excipient) Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Albumin (as Excipient) Sales Share by Application (2026-2031)
Figure 36. Global Albumin (as Excipient) Revenue Share by Application (2026-2031)
Figure 37. Global Albumin (as Excipient) Sales Share by Company (2024)
Figure 38. Global Albumin (as Excipient) Revenue Share by Company (2024)
Figure 39. Global 5 Largest Albumin (as Excipient) Players Market Share by Revenue in Albumin (as Excipient): 2020 & 2024
Figure 40. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Albumin (as Excipient)
Figure 42. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 43. Albumin (as Excipient) Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Table 1. Global Albumin (as Excipient) Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Albumin (as Excipient) Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Albumin (as Excipient) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Albumin (as Excipient) Sales (MT) by Region (2020-2025)
Table 5. Global Albumin (as Excipient) Sales Market Share by Region (2020-2025)
Table 6. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Albumin (as Excipient) Revenue Share by Region (2020-2025)
Table 8. Global Albumin (as Excipient) Sales (MT) Forecast by Region (2026-2031)
Table 9. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Albumin (as Excipient) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Albumin (as Excipient) Revenue Share Forecast by Region (2026-2031)
Table 12. Global Albumin (as Excipient) Sales by Type (MT) & (2020-2025)
Table 13. Global Albumin (as Excipient) Sales Share by Type (2020-2025)
Table 14. Global Albumin (as Excipient) Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Albumin (as Excipient) Price by Type (USD/Kg) & (2020-2025)
Table 16. Global Albumin (as Excipient) Sales by Type (MT) & (2026-2031)
Table 17. Global Albumin (as Excipient) Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Albumin (as Excipient) Price by Type (USD/Kg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Albumin (as Excipient) Sales by Application (MT) & (2020-2025)
Table 21. Global Albumin (as Excipient) Sales Share by Application (2020-2025)
Table 22. Global Albumin (as Excipient) Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Albumin (as Excipient) Price by Application (USD/Kg) & (2020-2025)
Table 24. Global Albumin (as Excipient) Sales by Application (MT) & (2026-2031)
Table 25. Global Albumin (as Excipient) Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Albumin (as Excipient) Price by Application (USD/Kg) & (2026-2031)
Table 27. New Sources of Growth in Albumin (as Excipient) Application
Table 28. Global Albumin (as Excipient) Sales by Company (MT) & (2020-2025)
Table 29. Global Albumin (as Excipient) Sales Share by Company (2020-2025)
Table 30. Global Albumin (as Excipient) Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Albumin (as Excipient) Revenue Share by Company (2020-2025)
Table 32. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
Table 33. Global Market Albumin (as Excipient) Average Price by Company (USD/Kg) & (2020-2025)
Table 34. Global Key Manufacturers of Albumin (as Excipient), Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Albumin (as Excipient), Product Type & Application
Table 36. Global Key Manufacturers of Albumin (as Excipient), Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. United States Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 39. United States Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 40. United States Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 41. United States Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 42. United States Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 43. United States Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 44. United States Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 45. United States Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 46. Europe Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 47. Europe Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 48. Europe Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 50. Europe Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 51. Europe Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 52. Europe Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 53. Europe Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 54. China Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 55. China Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 56. China Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 58. China Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 59. China Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 60. China Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 61. China Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 62. Japan Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 63. Japan Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 64. Japan Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 66. Japan Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 67. Japan Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 68. Japan Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 69. Japan Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 70. Australia Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 71. Australia Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 72. Australia Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 73. Australia Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 74. Australia Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 75. Australia Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 76. Australia Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 77. Australia Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 78. India Albumin (as Excipient) Sales by Company (2020-2025) & (MT)
Table 79. India Albumin (as Excipient) Sales Market Share by Company (2020-2025)
Table 80. India Albumin (as Excipient) Revenue by Company (2020-2025) & (US$ Million)
Table 81. India Albumin (as Excipient) Revenue Market Share by Company (2020-2025)
Table 82. India Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
Table 83. India Albumin (as Excipient) Sales Market Share by Type (2020-2025)
Table 84. India Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
Table 85. India Albumin (as Excipient) Sales Market Share by Application (2020-2025)
Table 86. CSL Company Information
Table 87. CSL Description and Business Overview
Table 88. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 89. CSL Albumin (as Excipient) Product
Table 90. CSL Recent Development
Table 91. Grifols Company Information
Table 92. Grifols Description and Business Overview
Table 93. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 94. Grifols Albumin (as Excipient) Product
Table 95. Grifols Recent Development
Table 96. Takeda Company Information
Table 97. Takeda Description and Business Overview
Table 98. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 99. Takeda Albumin (as Excipient) Product
Table 100. Takeda Recent Development
Table 101. Octapharma Company Information
Table 102. Octapharma Description and Business Overview
Table 103. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. Octapharma Albumin (as Excipient) Product
Table 105. Octapharma Recent Development
Table 106. Hualan Bio Company Information
Table 107. Hualan Bio Description and Business Overview
Table 108. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 109. Hualan Bio Albumin (as Excipient) Product
Table 110. Hualan Bio Recent Development
Table 111. CBPO Company Information
Table 112. CBPO Description and Business Overview
Table 113. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 114. CBPO Albumin (as Excipient) Product
Table 115. CBPO Recent Development
Table 116. Shanghai RAAS Company Information
Table 117. Shanghai RAAS Description and Business Overview
Table 118. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 119. Shanghai RAAS Albumin (as Excipient) Product
Table 120. Shanghai RAAS Recent Development
Table 121. Kedrion Company Information
Table 122. Kedrion Description and Business Overview
Table 123. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 124. Kedrion Albumin (as Excipient) Product
Table 125. Kedrion Recent Development
Table 126. LFB Group Company Information
Table 127. LFB Group Description and Business Overview
Table 128. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 129. LFB Group Albumin (as Excipient) Product
Table 130. LFB Group Recent Development
Table 131. Albumedix Company Information
Table 132. Albumedix Description and Business Overview
Table 133. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 134. Albumedix Albumin (as Excipient) Product
Table 135. Albumedix Recent Development
Table 136. Biotest Company Information
Table 137. Biotest Description and Business Overview
Table 138. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 139. Biotest Albumin (as Excipient) Product
Table 140. Biotest Recent Development
Table 141. Merck Company Information
Table 142. Merck Description and Business Overview
Table 143. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 144. Merck Albumin (as Excipient) Product
Table 145. Merck Recent Development
Table 146. Ventria (InVitria) Company Information
Table 147. Ventria (InVitria) Description and Business Overview
Table 148. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 149. Ventria (InVitria) Albumin (as Excipient) Product
Table 150. Ventria (InVitria) Recent Development
Table 151. HiMedia Company Information
Table 152. HiMedia Description and Business Overview
Table 153. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 154. HiMedia Albumin (as Excipient) Product
Table 155. HiMedia Recent Development
Table 156. Production Base and Market Concentration Rate of Raw Material
Table 157. Key Suppliers of Raw Materials
Table 158. Albumin (as Excipient) Distributors List
Table 159. Albumin (as Excipient) Customers List
Table 160. Albumin (as Excipient) Market Trends
Table 161. Albumin (as Excipient) Market Drivers
Table 162. Albumin (as Excipient) Market Challenges
Table 163. Albumin (as Excipient) Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Albumin (as Excipient) Product Picture
Figure 2. Global Albumin (as Excipient) Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Albumin (as Excipient) Sales Market Share by Type in 2024 & 2031
Figure 4. Human Serum Albumin Product Picture
Figure 5. Recombinant Albumin Product Picture
Figure 6. Global Albumin (as Excipient) Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Albumin (as Excipient) Sales Market Share by Application in 2024 & 2031
Figure 8. Cell Culture Media Examples
Figure 9. Medical Supplements Examples
Figure 10. Therapeutics Examples
Figure 11. Global Albumin (as Excipient) Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Albumin (as Excipient) Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 14. Global Albumin (as Excipient) Price Trends Growth Rate (2020-2031) & (USD/Kg)
Figure 15. Albumin (as Excipient) Report Years Considered
Figure 16. Global Market Albumin (as Excipient) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Albumin (as Excipient) Revenue Market Share by Region: 2020 VS 2024
Figure 18. United States Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. United States Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 20. Europe Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 22. China Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 24. Japan Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 26. Australia Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Australia Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 28. India Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Albumin (as Excipient) Sales (MT) Growth Rate (2020-2031)
Figure 30. Global Albumin (as Excipient) Revenue Share by Type (2020-2025)
Figure 31. Global Albumin (as Excipient) Sales Share by Type (2026-2031)
Figure 32. Global Albumin (as Excipient) Revenue Share by Type (2026-2031)
Figure 33. Global Albumin (as Excipient) Revenue Share by Application (2020-2025)
Figure 34. Global Albumin (as Excipient) Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Albumin (as Excipient) Sales Share by Application (2026-2031)
Figure 36. Global Albumin (as Excipient) Revenue Share by Application (2026-2031)
Figure 37. Global Albumin (as Excipient) Sales Share by Company (2024)
Figure 38. Global Albumin (as Excipient) Revenue Share by Company (2024)
Figure 39. Global 5 Largest Albumin (as Excipient) Players Market Share by Revenue in Albumin (as Excipient): 2020 & 2024
Figure 40. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Albumin (as Excipient)
Figure 42. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 43. Albumin (as Excipient) Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232